Literature DB >> 8163055

Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.

M A Gall1, P Rossing, A Kofoed-Enevoldsen, F S Nielsen, H H Parving.   

Abstract

In an attempt to evaluate the mechanisms of proteinuria in diabetic kidney disease, we measured the renal clearances of albumin, total IgG, and IgG4 in 20 male Type 2 (non-insulin-dependent) diabetic patients with diabetic glomerulosclerosis (biopsy proven), in 10 male Type 2 diabetic patients without nephropathy (urinary albumin excretion rate < or = 30 mg/24 h), and in 10 healthy male subjects. The fractional clearance of albumin was increased in patients with nephropathy: 659 (42-4355) x 10(-6) (median (range)), compared to 2.6 (0.2-14.2) x 10(-6) in patients without nephropathy, and 2.3 (0.4-4.2) x 10(-6) in healthy subjects. The fractional clearance of total IgG (neutral) and of IgG4 (anionic) was 40-50 times higher in patients with nephropathy compared to the two other groups. The IgG/IgG4 selectivity index was not significantly different in the three groups, being: 1.12 (0.06-5.65), 1.16 (0.45-3.72) and 1.35 (0.65-3.34) in patients with nephropathy, patients without nephropathy, and healthy subjects, respectively. The IgG/albumin selectivity index was decreased in patients with nephropathy: 0.27 (0.01-1.26) compared to 1.29 (0.07-2.67) (p < 0.05) and 1.23 (0.76-7.84) (p < 0.001) in patients without nephropathy and healthy subjects, respectively. No significant change in IgG/albumin selectivity index was observed between patients without nephropathy and healthy subjects. The systolic blood pressure was elevated in the patients with nephropathy: 164 +/- 21 mm Hg (mean +/- SD) compared to patients without nephropathy: 145 +/- 20 mm Hg (p < 0.05) and to healthy subjects: 133 +/- 19 mm Hg (p < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163055     DOI: 10.1007/s001250050093

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  [Fully mechanized kinetic measurement of creatinine].

Authors:  R Ullmann; K Bonitz
Journal:  Med Lab (Stuttg)       Date:  1976-06

Review 2.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

Authors:  T H Hostetter; H G Rennke; B M Brenner
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

3.  A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy.

Authors:  H H Parving; U M Smidt; B Friisberg; V Bonnevie-Nielsen; A R Andersen
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

4.  Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1977-10       Impact factor: 1.713

5.  Glomerular size and charge selectivity in insulin-dependent diabetes mellitus.

Authors:  T Deckert; B Feldt-Rasmussen; R Djurup; M Deckert
Journal:  Kidney Int       Date:  1988-01       Impact factor: 10.612

6.  Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria.

Authors:  H J Bangstad; A Kofoed-Enevoldsen; K Dahl-Jørgensen; K F Hanssen
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

7.  Charge selectivity of proteinuria in diabetic glomerulopathy.

Authors:  Y Nakamura; B D Myers
Journal:  Diabetes       Date:  1988-09       Impact factor: 9.461

8.  Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.

Authors:  R L Vernier; M W Steffes; S Sisson-Ross; S M Mauer
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

9.  Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients.

Authors:  H H Parving; M A Gall; P Skøtt; H E Jørgensen; H Løkkegaard; F Jørgensen; B Nielsen; S Larsen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more
  5 in total

1.  Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

Authors:  Tomohito Gohda; William H Walker; Pawel Wolkow; Jung Eun Lee; James H Warram; Andrzej S Krolewski; Monika A Niewczas
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-18

2.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

3.  Psammomys obesus, a particularly important animal model for the study of the human diabetic nephropathy.

Authors:  Pnina Scherzer; Shachaf Katalan; Gay Got; Galina Pizov; Irene Londono; Anca Gal-Moscovici; Mordecai M Popovtzer; Ehud Ziv; Moise Bendayan
Journal:  Anat Cell Biol       Date:  2011-09-29

4.  Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.

Authors:  Ole Torffvit; Majid Kalani; Jan Apelqvist; Björn Eliasson; Jan W Eriksson; Kerstin Brismar; Gun Jörneskog
Journal:  Biochem Res Int       Date:  2012-02-12

5.  Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

Authors:  Claire C J Dekkers; Sergei Petrykiv; Gozewijn D Laverman; David Z Cherney; Ron T Gansevoort; Hiddo J L Heerspink
Journal:  Diabetes Obes Metab       Date:  2018-04-23       Impact factor: 6.577

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.